CIK 0000872912 · Non-accelerated filer<br>Smaller reporting company
DELCATH SYSTEMS, INC.
Sign in to watch- Ticker
- DCTH
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061245881
- Phone
- (518) 743-8892
- Business address
- 566 QUEENSBURY AVENUE, QUEENSBURY, NY, 12804
- Former names
- DELCATH SYSTEMS, INC., DELCATH SYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $488,508
- in 1 filing
Net −$488,508. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-07 | Muir Kevin GM INTERVENTIONAL ONCOLOGY | Grant or award · Stock Option (Right to Buy) | +113,000 | 113,000 | ||
| 2025-02-07 | Rook Martha S. CHIEF OPERATING OFFICER | Grant or award · Stock Option (Right to Buy) | +113,000 | 113,000 | ||
| 2025-02-07 | Vukovic Vojo CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +113,000 | 113,000 | ||
| 2025-02-07 | MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +390,000 | 390,000 | ||
| 2024-12-24 | SALAMON STEVEN A J Director | Conversion | +250,000 | $10.00 | $2.5M | 3,013,468 |
| 2024-12-24 | SALAMON STEVEN A J Director | Option exercise · Pre-funded Warrants | +603,954 | $9.99 | $6.0M | 1,323,919 |
| 2024-12-24 | Aharon Gil Director | Conversion | +250,000 | $10.00 | $2.5M | 3,013,468 |
| 2024-12-24 | Aharon Gil Director | Option exercise · Pre-funded Warrants | +603,954 | $9.99 | $6.0M | 1,323,919 |
| 2024-12-24 | Rosalind Advisors, Inc. Director | Conversion | +250,000 | $10.00 | $2.5M | 3,013,468 |
| 2024-12-24 | Rosalind Advisors, Inc. Director | Option exercise · Pre-funded Warrants | +603,954 | $9.99 | $6.0M | 1,323,919 |
| 2024-10-30 | Aharon Gil Director | Option exercise · Tranche B warrants to purchase F-4 Preferred Stock | +500 | $1,000.00 | $500K | 0 |
| 2024-10-30 | Aharon Gil Director | Other acquisition · 8% CONVERTIBLE NOTE | +0 | 0 | ||
| 2024-10-30 | SALAMON STEVEN A J Director | Option exercise · Tranche B warrants to purchase F-4 Preferred Stock | +500 | $1,000.00 | $500K | 0 |
| 2024-10-30 | SALAMON STEVEN A J Director | Other acquisition · 8% CONVERTIBLE NOTE | +0 | 0 | ||
| 2024-10-30 | Rosalind Advisors, Inc. Director | Option exercise · Tranche B warrants to purchase F-4 Preferred Stock | +500 | $1,000.00 | $500K | 0 |
| 2024-10-30 | Rosalind Advisors, Inc. Director | Other acquisition · 8% CONVERTIBLE NOTE | +0 | 0 | ||
| 2024-10-22 | MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Option exercise | +16,666 | $6.00 | $100K | 319,334 |
| 2024-10-22 | MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Option exercise · Tranche B Warrants to Purchase Common Stock | −16,666 | $0.13 | $2K | 0 |
| 2024-05-23 | CZEREPAK ELIZABETH Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2024-05-23 | Sylvester John Richard Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 |
Page 3 of 7 · 138 trades